Integumen Share Chat (SKIN)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Integumen	LSE:SKIN	London	Ordinary Share	GB00BYWJ6269	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	2.775p	2.75p	2.80p	2.775p	2.775p	2.775p	0	08:00:00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
	0.1	-1.1	29.0	0.1	4.60

Integumen Share Discussion Threads

Showing 26 to 47 of 50 messages

Chat Pages: 2 1

Date	Subject	Author	Discuss
29/8/2017 14:13	Short lived....	philoosh	Read Full Thread Reply
24/8/2017 11:17	A rise..... Who bought ?	philoosh	Read Full Thread Reply
15/8/2017 18:22	Probably some initial investor selling out	cocker	Read Full Thread Reply
15/8/2017 17:16	So what's going on today, news coming, looks like an exodus!	admac	Read Full Thread Reply
03/7/2017 10:39	This is a dead ducky !!! No movements at all.	philoosh	Read Full Thread Reply
02/6/2017 16:58	I clearly need to go back to the 80's, get a sharp suit and go back to BS sales school.	yump	Read Full Thread Reply
02/6/2017 16:44	I don't know Yump, promise the earth & tell peeps global market worth 2 billion a year. Then place begging bowl out every six months & see how things turn out. What would be interesting is to know how many aim listed companies actually make a profit or get anywhere near their predicted revenues. Aim has always been a bit if a gamble & I except that. However, of late it has become a circus.	cocker	Read Full Thread Reply
02/6/2017 16:22	Wow, they've just made more revenue than one of my websites, except that the expenses for it are in thousands... I wonder if I could float for a couple of mill ? The only problem is I don't have any story other than 'to make profits from running a website', so a float is a non-starter ;-)	yump	Read Full Thread Reply
02/6/2017 13:57	There has been no movement on this since its IPO other than down. Is there any future in this share ?	philoosh	Read Full Thread Reply
02/6/2017 08:11	Exciting set of results !. Give it 12 more months before the begging bowl is out again	cocker	Read Full Thread Reply
08/5/2017 12:13	Well this seems to be a very lazy puppy !!!	philoosh	Read Full Thread Reply
11/4/2017 07:13	New Asian supply contract for Integumen's TS1 and first orders received - over 500,000 of these disposable products have already been sold by Integumen: Http://www.investegate.co.uk/integumen-plc--skin-/rns/supply-agreement-in-asia/201704110700171060C/	rivaldo	Read Full Thread Reply
08/4/2017 14:34	Thanks Griffin81	orm5	Read Full Thread Reply
08/4/2017 11:23	I don't think the website shows up on google searches yet. Links below to SKIN and the company it has been spun out from:http://www.integumen.co.uk/http://www.vennlifesciences.com/ipo-integumen-plc/	griffin81	Read Full Thread Reply
07/4/2017 20:41	Does this company have a website ?	orm5	Read Full Thread Reply
07/4/2017 20:22	I guess some shares are not for the faint hearted if you are trading day to day.	mulligut	Read Full Thread Reply
07/4/2017 11:37	heading for half a penny	larva	Read Full Thread Reply
06/4/2017 14:34	Rivaldo I am not a day trader so none of that particularly causes me any major concern. This is another share just like any other and hopefully based on what was done with Venn their management can drive value in the long term. I would expect that a decent newsflow regime for breakthrough products and distribution agreements will do a good bit for the share price. Long term it remains a very small part of my portfolio.	mulligut	Read Full Thread Reply
06/4/2017 11:44	Rivaldo. Just goes to show how many threads I have set up. Okay I agree that would be a good idea and the new thread is http://uk.advfn.com/cmn/fbb/thread.php3?id=41052994 here.	mulligut	Read Full Thread Reply
06/4/2017 11:42	Integumen has acquired and developed an advanced portfolio of technologies focused on premium products for the skin, oral and health care sector. Management have extensive experience in the commercialisation of these technologies with access to direct retail market distribution channels. Recent funding and admission to AIM has provided the support and public media exposure to further commercialise its already launched products, and bring its late stage development portfolio to market. With more than half a million Tongue Sanitisation disposable oral hygiene products sold since 2015, there is an opportunity to expand the distribution within the dental market in a strategy of high growth offering high value for other products in the pipeline. “Enhance Skin”, “Visible Youth” and “Clarogel̶1; product range of consumer and professional skincare products offer a consumer brand backed up by patented co-formulation of medical grade hyaluronic acid (HA). This offers additional opportunities for extension of distribution channels in Europe and the US. “Labskin”; provides unique access to in-house assessment of skin care ingredients and formulations offering accelerated evaluation to the most comprehensive range of tests available in an in vitro model, leading to early commercialisation of existing and future product formulations. The above is my assessment of the opportunity and I have decided to spread some of my monthly buying of Venn to a small purchase of shares in this company for the next few months. In the interest of fredome of speech, I welcome any comments, positive, in support or otherwise. Good luck to all.	mulligut	Read Full Thread Reply
06/4/2017 11:17	Mulligut, thx for setting this up. Being a pedant though - you haven't actually got the name of the company in the thread! Which doesn't help with publicising it. Perhaps you could set up a replacement thread called "Integumen - skin in the game"? No probs if you can't be bothered!	rivaldo	Read Full Thread Reply
06/4/2017 09:39	!FOLLOWFEED Integumen has acquired and developed an advanced portfolio of technologies focused on premium products for the skin, oral and health care sector. Management have extensive experience in the commercialisation of these technologies with access to direct retail market distribution channels. Recent funding and admission to AIM has provided the support and public media exposure to further commercialise its already launched products, and bring its late stage development portfolio to market. With more than half a million Tongue Sanitisation disposable oral hygiene products sold since 2015, there is an opportunity to expand the distribution within the dental market in a strategy of high growth offering high value for other products in the pipeline. “Enhance Skin”, “Visible Youth” and “Clarogel̶1; product range of consumer and professional skincare products offer a consumer brand backed up by patented co-formulation of medical grade hyaluronic acid (HA). This offers additional opportunities for extension of distribution channels in Europe and the US. “Labskin”; provides unique access to in-house assessment of skin care ingredients and formulations offering accelerated evaluation to the most comprehensive range of tests available in an in vitro model, leading to early commercialisation of existing and future product formulations. The above is my assessment of the opportunity and I have decided to spread some of my monthly buying of Venn to a small purchase of shares in this company for the next few months. In the interest of fredome of speech, I welcome any comments, positive, in support or otherwise. Good luck to all.	mulligut	Read Full Thread Reply

Chat Pages: 2 1

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.